Stock RVNC REVANCE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Revance Therapeutics, Inc.

Equities

RVNC

US7613301099

Market Closed - Nasdaq
Other stock markets
 01:30:00 04/06/2024 am IST 		5-day change 1st Jan Change
3.01 USD +5.99% Intraday chart for Revance Therapeutics, Inc. +11.07% -65.76%
10/05 Needham Adjusts Price Target on Revance Therapeutics to $12 From $18, Maintains Buy Rating MT
10/05 Piper Sandler Cuts Price Target on Revance Therapeutics to $11 From $20, Maintains Overweight Rating MT
4d3d39814212e33036.ESM1pjl7bVQkZu625ecJq2-L60phJXw8HMygFS-_Dso.ZBtZn3AkXzNMJarEkL9E4j-_hxlXQTgRT-Hxfkb7Yb9Va3zDCjg3AWdVtw~46df82286e34c8a05f9d6f4eeb771ff1
  1. Stock Market
  2. Equities
  3. RVNC Stock
  4. Charts Revance Therapeutics, Inc.
  5. News Chart